ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Board Change

21/12/2004 5:06pm

UK Regulatory


RNS Number:7049G
Celsis International PLC
21 December 2004

                            CELSIS INTERNATIONAL PLC


                         Non-Executive Director Change


21 December 2004: Celsis International plc, the microbial detection and
analytical services company, today announces that Mr John Morris has stood down
as non-executive director of the board.  Mr Morris, age 75, has served as a
non-executive director of Celsis since the company floated on the London Stock
Exchange in 1993.

Jack Rowell, Chairman of Celsis, commented:

"We are grateful to John for the tremendous contribution he has made to Celsis
over the last eleven years.  Celsis has developed significantly during this time
and we thank John for his dedicated enthusiasm.  I speak for the board when I
wish John our very best for the future."


Enquiries:

Celsis International plc                                      Tel: 01638 600 151
Jay LeCoque, Chief Executive Officer
Jenny Parsons, Corporate Communications

Financial Dynamics                                            Tel: 020 7831 3113
David Yates
Lucy Briggs



Notes to editors

Celsis International plc

Celsis International plc is a microbial detection and analytical services
company operating through two divisions, the Product Group and the Laboratory
Group.

Using its proprietary enzyme technology, the Product Group is the world leader
in the provision of diagnostic systems for the rapid detection of microbial
contamination.  It works in close collaboration with many of the world's leading
pharmaceutical, personal care and beverage companies, ensuring the safety and
quality of products bound for consumers.  The Laboratory Group provides
outsourced analytical testing services to pharmaceutical companies to ensure the
stability and chemical composition of their products.

In addition to ensuring product quality and safety for consumers, both divisions
have the capacity to deliver substantial cost savings to Celsis' customers.  By
reducing the time it takes to test and release raw materials and finished goods
to the market place, Celsis' products facilitate increased manufacturing
productivity and improved supply chain management.

Celsis International plc is listed on the London Stock Exchange (CEL.L).
Further information can be found on the Company's website at www.celsis.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAQKDKKOBDDKBB

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock